Structures by: Więckowska-Szakiel M.
Total: 8
C17H25Cl4N3RuS
C17H25Cl4N3RuS
RSC Advances (2019) 9, 66 38629
a=13.077(7)Å b=14.235(6)Å c=23.698(10)Å
α=90° β=90° γ=90°
C15H22ClN3O2RuS
C15H22ClN3O2RuS
RSC Advances (2019) 9, 66 38629
a=10.398(2)Å b=12.551(3)Å c=13.766(5)Å
α=90° β=90° γ=90°
C20H22ClN3ORuS
C20H22ClN3ORuS
RSC Advances (2019) 9, 66 38629
a=10.6196(18)Å b=12.7321(17)Å c=14.8584(15)Å
α=90° β=107.980(11)° γ=90°
C18H27Cl2N3RuS
C18H27Cl2N3RuS
RSC Advances (2019) 9, 66 38629
a=10.6918(18)Å b=14.539(2)Å c=26.597(4)Å
α=90° β=90° γ=90°
Chlorido-(2,2-dimethylaziridine)-[2-{1-(dimethylaminoethyl} phenyl-C,N]-palladium(II)
C14H23ClN2Pd
Dalton Transactions (2012) 41, 19 5925
a=10.7546(5)Å b=26.4634(11)Å c=11.0319(4)Å
α=90.00° β=92.912(3)° γ=90.00°
(Bis(N-(2-aminoethyl)aziridine- N,N)palladium(ii))bis(trifluormethansulfonate)
C8H20N4Pd,2(CF3O3S)
Dalton Transactions (2012) 41, 19 5925
a=11.6261(3)Å b=9.8324(2)Å c=9.8676(2)Å
α=90.00° β=111.6582(13)° γ=90.00°
Trans-bis[(2H-phenylazirine)dichlorido]palladium(II)
C16H14Cl2N2Pd
Dalton Transactions (2012) 41, 19 5925
a=21.4333(5)Å b=5.64490(10)Å c=12.6506(3)Å
α=90.00° β=90.00° γ=90.00°
[Tris(N-(2-aminoethyl)aziridine-N,N)copper(II)]dichloride
C16H36ClCuN4,Cl
Dalton Transactions (2012) 41, 19 5925
a=24.9994(5)Å b=9.05370(10)Å c=18.8146(3)Å
α=90.00° β=90.00° γ=90.00°